A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：ACTA NEUROPATHOLOGICA COMMUNICATIONS ISSN： 2051-5960 出版频率： Continuous publication 出版社： BMC, CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW   出版社网址： https://www.biomedcentral.com/ 期刊网址： https://actaneurocomms.biomedcentral.com/ 影响因子： 7.801 主题范畴： NEUROSCIENCES 变更情况： Newly Added by 2017 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and scope Acta Neuropathologica Communications (ANC) publishes articles on mechanisms of neurological disease based on experimental or human tissues using molecular, cellular and morphological techniques within two months following submission. Open access All articles published by Acta Neuropathologica Communications are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. As authors of articles published in Acta Neuropathologica Communications you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement. For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed. Article-processing charges Open access publishing is not without costs. Acta Neuropathologica Communicationstherefore levies an article-processing charge of £950.00/$1485.00/€1210.00 for each article accepted for publication, plus VAT or local taxes where applicable. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service. Indexing services All articles published in Acta Neuropathologica Communications are included in: Science Citation Index Expanded PubMed ​PubMed Central MEDLINE Scopus The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink. Acta Neuropathologica Communications has been selected for indexing in Web of Science and is currently being tracked by Clarivate Analytics to determine its Impact Factor. Acta Neuropathologica Communications will recieve its first Impact Factor in 2018. Peer-review policy Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here. Acta Neuropathologica Communications operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript. Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board. Editorial policies All manuscripts submitted to Acta Neuropathologica Communications should adhere to BioMed Central's editorial policies. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Appeals and complaints If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher. Citing articles in Acta Neuropathologica Communications Articles in Acta Neuropathologica Communications should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number. Article citations follow this format: Authors: Title. Acta Neuropathol Commun [year], [volume number]:[article number]. e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Acta Neuropathol Commun 2009, 1:115. refers to article 115 from Volume 1 of the journal. Instructions to Authors Submission guidelines Our 3-step submission process   Before you submit Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit. Make sure you are submitting to the most suitable journal -Aims and scope Understand the costs and funding options -Fees and funding Make sure your manuscript is accurate and readable -Language editing services Understand the copyright agreement -Copyright   Ready to submit To give your manuscript the best chance of publication, follow these policies and formatting guidelines. Acta Neuropathologica Communications publishes the following article types: Research Case report Letter to the Editor Methodology Review Click the relevant link to find style and formatting information for the article you are going to submit. General formatting rules for all article types -Preparing your manuscript Make sure your submission is complete -Prepare supporting information Copyright and license agreement -Conditions of publication Read and agree to our Editorial Policies -Editorial policies   Submit and promote After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond. Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.  Who decides whether my work will be accepted? -Peer-review policy Want to submit to a different journal? -Manuscript transfers Spreading the word -Promoting your publication Submit your manuscript in Editorial Manager Editorial Board Editors-in-Chief Werner Paulus, University of Münster, Germany Johannes Attems, Newcastle University, UK Editors Patrick Hof, Icahn School of Medicine at Mount Sinai, New York, USA Jeroen Hoozemans, VU University Medical Center, Netherlands Jason T Huse, Memorial Sloan-Kettering Cancer Center, USA Kurt Jellinger, Institute of Clinical Neurobiology, Austria Beatriz Lopes, University of Virginia, USA Marta Margeta, University of California San Francisco, USA Wendy Noble, Kings College London, UK Anna Oevermann, Vetsuisse Faculty, Switzerland Sheila K Singh, McMaster University, Canada Anna Williams, University of Edinburgh, UK Osamu Yokota, Okayama University, Japan